Literature DB >> 4367244

In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate.

C Jasmin, J C Chermann, G Herve, A Teze, P Souchay, C Boy-Loustau, N Raybaud, F Sinoussi, M Raynaud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4367244     DOI： 10.1093/jnci/53.2.469

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  14 in total

Review 1.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

2.  Mechanism of polyoxometalate-mediated inactivation of DNA polymerases: an analysis with HIV-1 reverse transcriptase indicates specificity for the DNA-binding cleft.

Authors:  S G Sarafianos; U Kortz; M T Pope; M J Modak
Journal:  Biochem J       Date:  1996-10-15       Impact factor: 3.857

Review 3.  Antiviral drugs for AIDS. Current status and future prospects.

Authors:  E Sandström
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

4.  Ammonium-5-tungsto-2-antimoniate (HPA23) can prevent fox rabies.

Authors:  M Pepin; J Blancou
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 5.  Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects.

Authors:  C U Tuazon; A M Labriola
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

6.  The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection.

Authors:  R H Kimberlin; C A Walker
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

7.  Experimental transmission of an autosomal dominant spongiform encephalopathy: does the infectious agent originate in the human genome?

Authors:  H F Baker; R M Ridley; T J Crow
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

8.  Inhibition of the wheat germ DNA polymerase A activity by the antiviral drug HPA-23.

Authors:  H Aoyama; M B Jucá; M Castroviejo; S Litvak
Journal:  Plant Mol Biol       Date:  1993-12       Impact factor: 4.076

Review 9.  Antiviral therapy in human immunodeficiency virus infection.

Authors:  E Sandström
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

10.  Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions.

Authors:  R H Kimberlin; C A Walker
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.